Advertisement

Dietary Cod Protein Improves Insulin Sensitivity in Insulin-Resistant Men and Women: A Randomized Controlled Trial

  1. Véronique Ouellet, BSc1,,2,
  2. Julie Marois, MSc1,,2,
  3. S John Weisnagel, MD, FRCPC3,,4 and
  4. Hélène Jacques, PhD (helene.jacques{at}aln.ulaval.ca)1,,2
  1. 1Institute of Nutraceuticals and Functional Foods, Laval University, Quebec, Canada
  2. 2Food Science and Nutrition, Laval University, Quebec, Canada
  3. 3Research Unit, CHUL Research Center, Quebec, Canada
  4. 4Social and Preventive Medicine, Division of Kinesiology, Laval University, Quebec, Canada

    Abstract

    OBJECTIVE: To compare the effects of cod protein to those of other animal proteins on insulin sensitivity in insulin-resistant human subjects.

    RESEARCH DESIGN AND METHODS: Insulin sensitivity (M/I) was assessed using a hyperinsulinemic-euglycemic clamp in 19 insulin-resistant subjects fed a cod protein (CP) diet and a similar diet containing lean beef, pork, veal, eggs, milk and milk products (BPVEM) for four weeks in a crossover design study. Both diets were formulated to differ only in protein source thus providing equivalent amounts of dietary fibres, monounsaturated, polyunsaturated (including omega-3) and saturated fatty acids (1.1:1.8:1.0). β-cell function, estimated by oral glucose tolerance test (OGTT)-derived parameters, was also assessed.

    RESULTS: There was a significant improvement in insulin sensitivity (P = 0.027) and a strong tendency for a better disposition index (β-cell function x M/I) (P = 0.055) in subjects consuming CP compared with BPVEM. When taking into account median baseline M/I (4.8x10-3 mg·kg-1·min-1·pmol-1), an interaction on 30-min C-peptide/30-min glucose ratio, used as an index of β-cell function, was observed between diet and M/I status (P = 0.022). Indeed, this ratio strongly tended to increase in subjects with low M/I consuming CP compared to BPVEM (P = 0.065).

    CONCLUSIONS: Dietary cod protein improves insulin sensitivity in insulin-resistant individuals, and thus could contribute to prevent type 2 diabetes by reducing the metabolic complications related to insulin resistance.

    CONCLUSIONS: Clinicaltrials.gov identification #NCT00400036.

    Footnotes

      • Received February 9, 2007.
      • Accepted July 31, 2007.

    This Article

    1. Diabetes Care August 6, 2007
    1. All Versions of this Article:
      1. dc07-0273v1
      2. 30/11/2816 most recent
    Advertisement